Pavmed Series Z Stock Cash And Equivalents

PAVMZ Stock  USD 0.03  0.00  0.00%   
PAVmed Series Z fundamentals help investors to digest information that contributes to PAVmed Series' financial success or failures. It also enables traders to predict the movement of PAVmed Stock. The fundamental analysis module provides a way to measure PAVmed Series' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PAVmed Series stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

PAVmed Series Z Company Cash And Equivalents Analysis

PAVmed Series' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

 = 

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

PAVmed Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for PAVmed Series is extremely important. It helps to project a fair market value of PAVmed Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since PAVmed Series' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PAVmed Series' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PAVmed Series' interrelated accounts and indicators.
0.3-0.58-0.660.750.451.00.790.780.7-0.66-0.160.810.610.820.670.820.810.210.780.870.21-0.43
0.3-0.940.51-0.28-0.70.380.470.1-0.260.180.720.790.93-0.23-0.44-0.23-0.26-0.74-0.290.38-0.740.7
-0.58-0.94-0.220.00.45-0.65-0.6-0.310.010.04-0.52-0.92-1.0-0.080.17-0.09-0.040.52-0.03-0.650.52-0.45
-0.660.51-0.22-0.92-0.97-0.6-0.35-0.66-0.860.760.74-0.110.18-0.91-0.96-0.9-0.92-0.77-0.91-0.5-0.770.92
0.75-0.280.0-0.920.860.720.570.880.96-0.91-0.590.340.020.840.950.840.820.580.80.570.58-0.72
0.45-0.70.45-0.970.860.390.20.560.8-0.72-0.8-0.12-0.420.780.930.780.810.80.80.270.8-0.95
1.00.38-0.65-0.60.720.390.790.780.67-0.64-0.130.850.670.770.620.770.750.150.730.90.15-0.35
0.790.47-0.6-0.350.570.20.790.80.57-0.610.250.850.60.480.450.480.52-0.260.380.47-0.26-0.16
0.780.1-0.31-0.660.880.560.780.80.86-0.92-0.210.610.310.640.730.640.620.190.560.570.19-0.39
0.7-0.260.01-0.860.960.80.670.570.86-0.88-0.540.320.010.780.930.780.760.540.740.530.54-0.67
-0.660.180.040.76-0.91-0.72-0.64-0.61-0.92-0.880.41-0.37-0.05-0.67-0.8-0.67-0.65-0.41-0.63-0.46-0.410.54
-0.160.72-0.520.74-0.59-0.8-0.130.25-0.21-0.540.410.350.48-0.48-0.63-0.48-0.49-0.8-0.55-0.25-0.80.74
0.810.79-0.92-0.110.34-0.120.850.850.610.32-0.370.350.920.360.170.360.34-0.360.280.72-0.360.15
0.610.93-1.00.180.02-0.420.670.60.310.01-0.050.480.920.11-0.150.110.07-0.50.060.68-0.50.42
0.82-0.23-0.08-0.910.840.780.770.480.640.78-0.67-0.480.360.110.91.00.970.680.990.680.68-0.78
0.67-0.440.17-0.960.950.930.620.450.730.93-0.8-0.630.17-0.150.90.90.880.710.870.460.71-0.85
0.82-0.23-0.09-0.90.840.780.770.480.640.78-0.67-0.480.360.111.00.90.970.680.990.680.68-0.78
0.81-0.26-0.04-0.920.820.810.750.520.620.76-0.65-0.490.340.070.970.880.970.60.970.60.6-0.86
0.21-0.740.52-0.770.580.80.15-0.260.190.54-0.41-0.8-0.36-0.50.680.710.680.60.730.271.0-0.75
0.78-0.29-0.03-0.910.80.80.730.380.560.74-0.63-0.550.280.060.990.870.990.970.730.680.73-0.82
0.870.38-0.65-0.50.570.270.90.470.570.53-0.46-0.250.720.680.680.460.680.60.270.680.27-0.22
0.21-0.740.52-0.770.580.80.15-0.260.190.54-0.41-0.8-0.36-0.50.680.710.680.61.00.730.27-0.75
-0.430.7-0.450.92-0.72-0.95-0.35-0.16-0.39-0.670.540.740.150.42-0.78-0.85-0.78-0.86-0.75-0.82-0.22-0.75
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition

In accordance with the recently published financial statements, PAVmed Series Z has 0.0 in Cash And Equivalents. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

PAVmed Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PAVmed Series' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PAVmed Series could also be used in its relative valuation, which is a method of valuing PAVmed Series by comparing valuation metrics of similar companies.
PAVmed Series is currently under evaluation in cash and equivalents category among its peers.

PAVmed Series Current Valuation Drivers

We derive many important indicators used in calculating different scores of PAVmed Series from analyzing PAVmed Series' financial statements. These drivers represent accounts that assess PAVmed Series' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PAVmed Series' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap30.8M21.4M100.6M42.8M29.8M57.7M
Enterprise Value31.3M21.1M98.3M39.6M58.9M62.0M

PAVmed Fundamentals

About PAVmed Series Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze PAVmed Series Z's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PAVmed Series using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PAVmed Series Z based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.